Palvella Therapeutics Inc (PVLA)
128.60
+6.80%
Palvella Therapeutics Inc (PVLA) is currently trading at $128.60. This represents a gain of 6.8% from the previous session. With a market capitalization of $1.52B, PVLA is a key component of the Nuclear Energy sector. Investors looking to trade PVLA should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade PVLA commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Palvella Therapeutics Inc (PVLA) shows a bullish trend. Analysts are watching the 129.32 level closely.
Fundamentals
Mkt Cap1.52B
P/E Ratio0.0000
Volume581,781
60-Day Technical Chart
Advanced Charting
Need more indicators for PVLA? Use the world's #1 platform.
Open PVLA on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $129
| Metric |
PVLA +6.80% |
PLTR +4.15% |
MSTR +8.86% |
WDAY +2.25% |
|---|---|---|---|---|
| Price | $128.60 | $134.19 | $135.65 | $133.16 |
| Mkt Cap | $1.52B | $320.80B | $43.23B | $35.02B |
| - | View → | View → | View → |
Latest Headlines
Palvella (PVLA) Stock Pre-Market (+13%): Phase 3 Topline Data Anticipation
Trefis • Feb 24, 2026
Palvella surges on late-stage trial win for lead asset
Seeking Alpha • Feb 24, 2026
$PVLA stock is up 37% today. Here's what we see in our data.
Quiver Quantitative • Feb 24, 2026
PVLA Stock Soars Pre-Market on Strong Phase 3 Results For Rare Vascular Disorder Treatment
Stocktwits • Feb 24, 2026
Rare lymphatic malformation trial results: Palvella sets QTORIN update call
Stock Titan • Feb 23, 2026
● Gemini Agentic AI Analyst Insight for PVLA
Market Education
- What is Pattern Day Trading rule (PDT) - Its limiting my trading. Jul 15, 2023
- Institutions vs Retail Traders - Showdown, Apes are winning May 24, 2021
- How can Retail Traders not lose money to Institutional Traders Jul 15, 2023
External Research